ASTERASYS Co.,Ltd (KOSDAQ:450950)
South Korea · Delayed Price · Currency is KRW 4,950.00
+10.00 (0.20%)
At close: Sep 11, 2026
ASTERASYS Co.,Ltd Revenue
ASTERASYS Co.,Ltd had revenue of 11.22B KRW in the quarter ending June 30, 2026, with 8.57% growth. This brings the company's revenue in the last twelve months to 39.61B, up 14.82% year-over-year. In the year 2025, ASTERASYS Co.,Ltd had annual revenue of 37.94B with 31.60% growth.
Revenue (ttm)
39.61B
Revenue Growth
+14.82%
P/S Ratio
4.70
Revenue / Employee
396.10M
Employees
94
Market Cap
186.26B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 37.94B | 9.11B | 31.60% |
| Dec 31, 2024 | 28.83B | 11.34B | 64.78% |
| Dec 31, 2023 | 17.50B | 1.88B | 12.04% |
| Dec 31, 2022 | 15.62B | 1.56B | 11.06% |
| Dec 31, 2021 | 14.06B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRGEM | 109.45B |
| MEDIANA Co.,Ltd | 71.45B |
| JPI Healthcare | 46.86B |
| L&K Biomed | 39.94B |
| Hironic | 37.10B |
| SELVAS Healthcare | 31.69B |
| Remed | 27.05B |
| Next Biomedical | 17.79B |